High-dose erythropoietin inhibits apoptosis and stimulates proliferation in neonatal rat intestine

Growth Hormone and IGF Research

Volumn 17, Issue 5, 2007, Pages 424-430

  McPherson, Ronald J ^a   Juul, Sandra E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; BrdU; Enterocyte; Ileum; Intestinal epithelial cell (IEC); Necrotizing enterocolitis; Recombinant human erythropoietin (rEpo)

Indexed keywords

BROXURIDINE; ERYTHROPOIETIN RECEPTOR; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALIBRATION; CELL DENSITY; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; DNA SYNTHESIS; DRUG MECHANISM; DRUG MEGADOSE; ILEUM; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE MUSCLE; NICK END LABELING; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BROMODEOXYURIDINE; CELL DIVISION; DNA REPLICATION; ENTEROCYTES; ERYTHROPOIETIN; IN SITU NICK-END LABELING; INTESTINES; KINETICS; MUSCLE, SMOOTH; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34548234917     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.05.006     Document Type: Article

References (51)

1. Oda A., et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Blood 92 (1998) 443-451
2. Yoshimura A., and Arai K. Physician education: the erythropoietin receptor and signal transduction. Oncologist 1 (1996) 337-339
3. Fiordaliso F., et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 102 (2005) 2046-2051
4. Rafiee P., et al. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic. Res. Cardiol. 100 (2005) 187-197
5. Dame C., Juul S.E., and Christensen R.D. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol. Neonate. 79 (2001) 228-235
6. Kumral A., et al. Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation. Biol. Neonate. 84 (2003) 325-329
7. Juul S.E., Anderson D.K., Li Y., and Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 43 (1998) 40-49
8. Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr. Suppl. 91 (2002) 36-42
9. Juul S.E., Yachnis A.T., and Christensen R.D. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum. Dev. 52 (1998) 235-249
10. Juul S.E., Joyce A.E., Zhao Y., and Ledbetter D.J. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr. Res. 46 (1999) 263-268
11. Juul S.E., et al. Erythropoietin acts as a trophic factor in neonatal rat intestine. Gut 49 (2001) 182-189
12. Ledbetter D.J., and Juul S.E. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J. Pediatr. Surg. 35 (2000) 178-181 discussion 182
13. Akisu M., Kullahcioglu Girgin F., Baka M., Husseyinov A., and Kultursay N. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. Eur. J. Pediatr. Surg. 11 (2001) 167-172
14. Lima-Rogel V., et al. Tolerance of a sterile isotonic electrolyte solution containing select recombinant growth factors in neonates recovering from necrotizing enterocolitis. J. Perinatol. 23 (2003) 200-204
15. Maheshwari A. Role of cytokines in human intestinal villous development. Clin. Perinatol. 31 (2004) 143-155
16. Warner B.W., and Warner B.B. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis. Semin. Pediatr. Surg. 14 (2005) 175-180
17. Halpern M.D., et al. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. J. Pediatr. Gastroenterol. Nutr. 36 (2003) 126-133
18. Halpern M.D., et al. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis. Biol. Neonate. 89 (2006) 227-235
19. Warner B.B., et al. Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J. Pediatr. 150 (2007) 358-363
20. Maheshwari A., et al. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr. Res. 56 (2004) 240-249
21. Maheshwari A., Lu W., Guida W.C., Christensen R.D., and Calhoun D.A. IL-8/CXC ligand 8 survives neonatal gastric digestion as a result of intrinsic aspartyl proteinase resistance. Pediatr. Res. 57 (2005) 438-444
22. Poulsom R., Begos D.E., and Modlin I.M. Molecular aspects of restitution: functions of trefoil peptides. Yale J. Biol. Med. 69 (1996) 137-146
23. Zhang B.H., Yu H.G., Sheng Z.X., Luo H.S., and Yu J.P. The therapeutic effect of recombinant human trefoil factor 3 on hypoxia-induced necrotizing enterocolitis in immature rat. Regul. Pept. 116 (2003) 53-60
24. Vieten D., Corfield A., Carroll D., Ramani P., and Spicer R. Impaired mucosal regeneration in neonatal necrotising enterocolitis. Pediatr. Surg. Int. 21 (2005) 153-160
25. Jilling T., Lu J., Jackson M., and Caplan M.S. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr. Res. 55 (2004) 622-629
26. Vieten D., Corfield A., Ramani P., and Spicer R. Proliferative response in necrotising enterocolitis is insufficient to prevent disease progression. Pediatr. Surg. Int. 22 (2006) 50-56
27. Younoszai M.K., and Ranshaw J. Gastrointestinal Growth in the Fetus and Suckling Rat Pups: Effects of Maternal Dietary Protein. J. Nutr. 103 (1973) 454-461
28. Okada A., et al. Erythropoietin stimulates proliferation of rat-cultured gastric mucosal cells. Digestion 57 (1996) 328-332
29. Wen D., et al. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 82 (1993) 1507-1516
30. Jilling T., et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J. Immunol. 177 (2006) 3273-3282
31. Kosloske A.M. Epidemiology of necrotizing enterocolitis. Acta Paediatr. Suppl Suppl 396 (1994) 2-7
32. Caplan M.S., and Jilling T. New concepts in necrotizing enterocolitis. Curr. Opin. Pediatr. 13 (2001) 111-115
33. Henning S.J. Ontogeny of enzymes in the small intestine. Ann. Rev. Physiol. 47 (1985) 231-245
34. Juul S., and Felderhoff-Mueser U. Epo and other hematopoietic factors. Semin. Fetal Neonatal. Med. (2007)
35. Kellert B., McPherson R.J., and Juul S.E. A comparison of high dose erythropoietin treatment regimens in brain injured neonatal rats. Pediat. Res. 61 (2007) 451-455
36. Ito Y., et al. Intestinal microcirculatory dysfunction during the development of experimental necrotizing enterocolitis. Pediatr. Res. 61 (2007) 180-184
37. Clark J.A., et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006) G938-G949
38. Nadler E.P., et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J. Surg. Res. 92 (2000) 71-77
39. Kosloske A.M., and Musemeche C.A. Necrotizing enterocolitis of the neonate. Clin. Perinatol. 16 (1989) 97-111
40. Dvorak B., et al. Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model. Pediatr. Res. 53 (2003) 426-433
41. Dvorak B., et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G156-G164
42. Chong Z.Z., Kang J.Q., and Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab. 22 (2002) 503-514
43. Gregoli P.A., and Bondurant M.C. The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood 90 (1997) 630-640
44. Clark J.A., et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol. (2004)
45. Sun Y., Calvert J.W., and Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36 (2005) 1672-1678
46. Lee R., Kertesz N., Joseph S.B., Jegalian A., and Wu H. Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis. Blood 98 (2001) 1408-1415
47. Kertesz N., Wu J., Chen T.H., Sucov H.M., and Wu H. The role of erythropoietin in regulating angiogenesis. Dev. Biol. 276 (2004) 101-110
48. Wu H., Liu X., Jaenisch R., and Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83 (1995) 59-67
49. Ashley R.A., et al. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr. Res. 51 (2002) 472-478
50. Wu H., Lee S.H., Gao J., Liu X., and Iruela-Arispe M.L. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126 (1999) 3597-3605
51. McPherson R.J., Demers E.J., and Juul S.E. Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology 91 (2007) 36-43